Versiti becomes 10th U.S. blood center to adopt FDA-cleared automation from Terumo Blood and Cell Technologies

Positive

AI Analysis

Summary

Versiti has become the 10th U.S. blood center to adopt Terumo Blood and Cell Technologies' FDA-cleared Reveos Automated Blood Processing System. The automated whole blood processing is intended to expand platelet production capacity and help meet growing hospital demand.

Outcome Details

Versiti became the 10th U.S. blood center to adopt the FDA-cleared Reveos Automated Blood Processing System from Terumo Blood and Cell Technologies.

Importance:2/10

Sentiment:

0.30

medical deviceblood processingautomationplatelet productionblood centerFDA-clearedReveos

Read the original article

Published by PR Newswire Pharma on October 19, 2026 2:00 PM

Read Original